Role of spiramycin in prevention of fetal toxoplasmosis

Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy

(2014) P Valentini et al.   Journal of Perinatology

CongenitalToxoplasmaInfection: Monthly Prenatal Screening Decreases Transmission Rate and Improves Clinical Outcome at Age 3 Years

(2013) M. Wallon et al.   CLINICAL INFECTIOUS DISEASES

Toxoplasma Seroconversion with Negative or Transient Immunoglobulin M in Pregnant Women: Myth or Reality? A French Multicenter Retrospective Study

(2013) H. Fricker-Hidalgo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Efficacy of Rapid Treatment Initiation Following Primary Toxoplasma gondii Infection During Pregnancy

(2012) A. Hotop et al.   CLINICAL INFECTIOUS DISEASES

Unresolved questions about the most successful known parasite

(2011) Daniel Ajzenberg   Expert Review of Anti-Infective Therapy

Accuracy of Real-Time Polymerase Chain Reaction for Toxoplasma gondii in Amniotic Fluid

(2010) Martine Wallon et al.   OBSTETRICS AND GYNECOLOGY

Clinical Practice: Management ofToxoplasma gondiiInfection during Pregnancy

(2008) Jose G. Montoya et al.   CLINICAL INFECTIOUS DISEASES

Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy

(2008) P. Valentini et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES